These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9475669)

  • 1. Nicotinic acid--the underused ally in the fight against coronary disease.
    O'Keefe JH; Harris WS
    J Cardiovasc Risk; 1997 Jun; 4(3):161-3. PubMed ID: 9475669
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niaspan: new hope for heart patients.
    Creavin T
    Drug Discov Today; 2005 Jan; 10(1):4-5. PubMed ID: 15676289
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotinic acid and the prevention of coronary artery disease.
    Digby JE; Lee JM; Choudhury RP
    Curr Opin Lipidol; 2009 Aug; 20(4):321-6. PubMed ID: 19494772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.
    Birjmohun RS; Hutten BA; Kastelein JJ; Stroes ES
    J Am Coll Cardiol; 2005 Jan; 45(2):185-97. PubMed ID: 15653014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review.
    Carlson LA
    J Intern Med; 2005 Aug; 258(2):94-114. PubMed ID: 16018787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niacin in patients with diabetes mellitus and coronary artery disease.
    Lavie CJ; Milani RV
    Am J Cardiol; 2001 May; 87(9):1137-8. PubMed ID: 11396426
    [No Abstract]   [Full Text] [Related]  

  • 8. New perspectives on the use of niacin in the treatment of lipid disorders.
    McKenney J
    Arch Intern Med; 2004 Apr; 164(7):697-705. PubMed ID: 15078639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line therapies for lowering triglyceride levels.
    Raghavan VA
    Am Fam Physician; 2008 Feb; 77(4):416; author reply 417-8. PubMed ID: 18326158
    [No Abstract]   [Full Text] [Related]  

  • 10. Bridging the gap in treatment options for patients with hypertriglyceridemia.
    Underberg JA; Hays R
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S24-31. PubMed ID: 18664339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin for high triglycerides.
    TreatmentUpdate; 2002 Nov; 14(8):7-8. PubMed ID: 12501829
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy and safety of immediate-release niacin in patients with ischemic cardiopathy. Experience of the Instituto Nacional de Cardiología "Ignacio Chávez"].
    Morato Hernández ML; Ichazo Cerro MS; Alvarado Vega AG; Zamora González J; Cardoso Saldaña GC; Posadas Romero C
    Arch Inst Cardiol Mex; 2000; 70(4):367-76. PubMed ID: 11075282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish oil supplements.
    Med Lett Drugs Ther; 2006 Jul; 48(1239):59-60. PubMed ID: 16841020
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety and tolerability of nicotinic acid. Results of the multicenter, open, prospective NAUTILUS study].
    Vogt A; Kassner U; Hostalek U; Peiter A; Steinhagen-Thiessen E
    MMW Fortschr Med; 2006 May; 148(18):41. PubMed ID: 16736688
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of nicotinic acid and bezafibrate alone and in combination for reducing serum triglyceride level.
    Pradhan B; Neopane A; Karki S; Karki DB
    Kathmandu Univ Med J (KUMJ); 2005; 3(4):411-4. PubMed ID: 16449845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic acid treatment shifts the fibrinolytic balance favourably and decreases plasma fibrinogen in hypertriglyceridaemic men.
    Johansson JO; Egberg N; Asplund-Carlson A; Carlson LA
    J Cardiovasc Risk; 1997 Jun; 4(3):165-71. PubMed ID: 9475670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intervention for hypertriglyceridemia].
    Nagao M; Oikawa S
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():257-63. PubMed ID: 17824043
    [No Abstract]   [Full Text] [Related]  

  • 19. Nicotinic acid in the treatment of lipid disorders.
    Labreche DG
    Pharmacotherapy; 1989; 9(4):270-1. PubMed ID: 2671960
    [No Abstract]   [Full Text] [Related]  

  • 20. Niacin and lipoprotein(a): facts, uncertainties, and clinical considerations.
    Scanu AM; Bamba R
    Am J Cardiol; 2008 Apr; 101(8A):44B-47B. PubMed ID: 18375241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.